From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Aggreko: supping at the temporary power share opportunity trough again

By Chris Bailey of Financial Orbit | Wednesday 3 August 2016


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


You would have thought I had learnt my lesson on the temporary power market following the disastrous APR Energy ‘excitements’ of a year plus ago. Perhaps I feel emboldened because the ultimate takeover of the company by a do-gooding consortium bailed me out on the name and added a touch of profit to boot. Alternatively I feel a touch of unfinished business on Aggreko (AGK) after calling the stock interesting when it exited the FTSE-100 fifteen months ago and it has quietly been one of the stars of my portfolio year-to-date. At least until today.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

Gold

Sprott bullish on gold

 

SOS

Sosandar: when is the warning?

 

SCGL

Evil Banksta: TW schoolboy error

 

ARB

Worthless Argo what news Helios?

Sunday »

Bearcast

Tom Winnifrith Bearcast: macrobabble calls

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 18:31:39